Rita Maria Concetta Di Martino

Our July issue is live! Read more about deuterium in drug discovery, amplifying gene expression with RNA-targeted therapies, accelerating antiviral discovery, including African data in drug R&D, RSV vaccines and more here bit.ly/46w4ncJ

Deuterium in drug discovery: progress, opportunities and challenges go.nature.com/3IZ1RSd A new review by @RitaMariaConce2 , Brad Maxwell and @TraceyPirali discussing how deuteration may improve the pharmacokinetic and/or toxicity profile of drugs (link corrected)

Deuterium in drug discovery: progress, opportunities and challengesgo.nature.com/3IZ1RSd A new review by @RitaMariaConce2 , Brad Maxwell and @TraceyPirali discussing how deuteration may improve the pharmacokinetic and/or toxicity profile of drugs

Our review on the use of deuterium in #DrugDiscovery has just been published with @SpringerNature in @NatRevDrugDisc! Check it out: rdcu.be/ddNWG nature.com/articles/s4157… @RitaMariaConce2 @UniAvogadro @VertexPharma #Chemistry #DrugDiscovery

A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs pubs.acs.org/doi/10.1021/ac…

ARN15381 is very much alive and kicking. Very nice results reported in this study coordinated by Nazzareno Cannella. The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases n... sciencedirect.com/science/articl…

Born #OnThisDay in 1909, Rita Levi-Montalcini studied how nerves grow and won a Nobel Prize for her work bit.ly/3wjCwwx #histsci (Image by audrey_sel via Wikimedia Commons)

Open postdoctoral position to join the Computer-assisted Molecular Design Lab at the Department of Biomolecular Sciences (DISB) of the University of Urbino. Just a few days left, deadline April 15th pica.cineca.it/uniurb/22ass01/

Exciting project in collaboration with a pharma company. Open postdoctoral position to join the Computer-assisted Molecular Design Lab at the Department of Biomolecular Sciences (DISB) of the University of Urbino Apply at: pica.cineca.it/uniurb/22ass01/

tandfonline.com/eprint/NC2VJNR… Check out our latest patent review on #D3R ligands for therapeutic intervention on CNS-associated disorders, cancer, and other conditions!! @CAMD_DISB 👇👇👇

Massive work by @RitaMariaConce2 on this review paper. Looking forward to new collaborations! Dopamine D3 receptor ligands: a patent review (2014-2020) tandfonline.com/doi/full/10.10…